CenTrial Logo

Are MRI scans useful for Detecting Brain Lesions in Multiple Sclerosis?


Clinical trial concludes the MRI scans are valuable for detecting the brain lesions of MS patients

The diagnosis of multiple sclerosis is a complex and difficult journey involving many tests and procedures which can not only give clues that help with the diagnosis but also help to rule out other diseases with similar symptoms.

A recent clinical trial has explored the use of an imaging test called magnetic resonance imaging (MRI) in diagnosing multiple sclerosis.

Multiple sclerosis is a neurological condition that affects millions of people worldwide. It is a chronic disease that affects the brain and spinal cord, causing symptoms such as muscle weakness, difficulty with coordination and balance, and problems with vision. It is a lifelong condition that can result in serious disability. It is one of the most common causes of disability in young adults.

There are many different ways to detect multiple sclerosis that include blood tests, spinal tap (lumbar puncture), MRI, and evoked potential tests that detect electrical signals produced by the brain and spinal cord. One of the main indicators of multiple sclerosis is the appearance of brain lesions, which can be seen on MRI scans. Gadolinium is a type of contrast material that is used during MRI scans to improve the visibility of certain types of tissue including the brain and spinal cord.

Recently, a clinical trial investigated the use of Gadolinium-enhanced MRI scans for detecting the brain lesions of multiple sclerosis patients.

The clinical study, published in the journal Neurologia (Engl Ed), involved 90 patients who had relapsed following previous treatment for multiple sclerosis. These patients underwent gadolinium-enhanced MRI at the onset of symptoms and after 15 days. The researchers aimed to determine whether gadolinium-enhanced MRI scans could provide more accurate information about the presence and extent of brain lesions in multiple sclerosis patients who were experiencing a relapse.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me
The results of the clinical trial showed that 62% of the patients had at least one brain lesion on MRI while 41% of the patients had two or more brain lesions. Only 30% of the patients with brain symptoms had no brain lesions on MRI. 

These results indicate that gadolinium-enhanced MRI scans could be used as a diagnostic modality for relapsing multiple sclerosis patients. Furthermore, these MRI scans also provided detailed information about the size and location of the brain lesions.
This information has important implications for doctors helping them make accurate decisions about management options for their patients.

Overall, this clinical study suggests that gadolinium-enhanced MRI scans may be a valuable tool for clinicians in the diagnosis and management of multiple sclerosis relapse. By providing more accurate information about the presence and extent of brain lesions, gadolinium-enhanced MRI scans may help clinicians make more informed decisions about treatment options for their patients.

In conclusion, this clinical trial emphasizes that gadolinium-enhanced MRI scans are a safe and effective diagnostic modality for accurately diagnosing multiple sclerosis. However, it is important to discuss all options with your doctor before deciding on the type of investigation that would be suitable for you.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Without participants there can be no clinical trials.
Without clinical trials there will be no new treatments.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.